BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Pasquale V, Scerra G, Scarcella M, D'Agostino M, Pavone LM. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB. Biochim Biophys Acta Mol Cell Res 2021;1868:119113. [PMID: 34329663 DOI: 10.1016/j.bbamcr.2021.119113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Scerra G, De Pasquale V, Scarcella M, Caporaso MG, Pavone LM, D'Agostino M. Lysosomal positioning diseases: beyond substrate storage. Open Biol 2022;12:220155. [PMID: 36285443 DOI: 10.1098/rsob.220155] [Reference Citation Analysis]
2 Brokowska J, Gaffke L, Pierzynowska K, Cyske Z, Węgrzyn G. Cell cycle disturbances in mucopolysaccharidoses: Transcriptomic and experimental studies on cellular models. Exp Biol Med (Maywood) 2022;:15353702221114872. [PMID: 36000158 DOI: 10.1177/15353702221114872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pan X, Taherzadeh M, Bose P, Heon-Roberts R, Nguyen ALA, Xu T, Pará C, Yamanaka Y, Priestman DA, Platt FM, Khan S, Fnu N, Tomatsu S, Morales CR, Pshezhetsky AV. Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT. J Exp Med 2022;219:e20211860. [PMID: 35704026 DOI: 10.1084/jem.20211860] [Reference Citation Analysis]
4 De Pasquale V, Scarcella M, Pavone LM. Molecular Mechanisms in Lysosomal Storage Diseases: From Pathogenesis to Therapeutic Strategies. Biomedicines 2022;10:922. [DOI: 10.3390/biomedicines10040922] [Reference Citation Analysis]
5 Lehmann RJ, Jolly LA, Johnson BV, Lord MS, Kim HN, Saville JT, Fuller M, Byers S, Derrick-Roberts ALK. Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells. Mol Genet Metab Rep 2021;29:100811. [PMID: 34712574 DOI: 10.1016/j.ymgmr.2021.100811] [Reference Citation Analysis]
6 Pan X, Taherzadeh M, Bose P, Heon-roberts R, Nguyen ALA, Xu T, Pará C, Yamanaka Y, Priestman DA, Platt FM, Khan S, Fnu N, Tomatsu S, Morales CR, Pshezhetsky AV. Oral Glucosamine Ameliorates Aggravated Neurological Phenotype in Mucopolysaccharidosis III Type C Mouse Model Expressing Misfolded HGSNAT Variant.. [DOI: 10.1101/2021.08.26.457793] [Reference Citation Analysis]